We are very proud to announce major progress in the search for a cure for sickle cell disease (SCD), the first genetic disease to be understood and a major disease that kills an estimated half-million people world-wide each year. As high as one in every four black persons in certain parts of Africa carries the sickle cell gene. In the United States the incidence is 1 in 12 for African Americans, and approximately 78,000 have SCD. Dr. Robert H. Broyles, a medical school professor and researcher in Oklahoma City, has discovered a protein that is grown in our own bodies that will silence the sickle cell gene and activate a normal gene in its place. Unlike current treatments that are only partially effective or treat the damage caused by SCD, this cure is very specific for the cause, easy to deliver, and beneficial to the whole body. We are working to get this treatment through safety trials and into the clinics where it will be available to all who have sickle cell disease. Our vision is a global one: our goal is to get this cure to each of the millions of people world-wide who have SCD and/or Beta-Thalassemia.